Senegal-made sickle cell treatment raises hopes, reduces costs
For the first time in Africa, a Senegalese laboratory is producing generic hydroxyurea, the gold standard in sickle cell treatment with the hopes of providing cheaper treatment medication.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on iol.co.za — the content belongs to IOL.
